| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000010210 |
| Receipt No. | R000011958 |
| Official scientific title of the study | A study of efficacy and safety of Transcatheter Arterial Embolization (TAE) with Embosphere for Polycystic liever disease. |
| Date of disclosure of the study information | 2013/03/11 |
| Last modified on | 2017/05/29 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | A study of efficacy and safety of Transcatheter Arterial Embolization (TAE) with Embosphere for Polycystic liever disease. | |
| Title of the study (Brief title) | Safety of Embosifere for polycystic liver disease. | |
| Region |
|
|
| Condition | |||
| Condition | Polycystic liver disease | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To examine a efficacy and safety of Transcatheter Arterial Embolization (TAE) with Embosphere in polycysitc liver disease patients. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Safety(Liver disfunction,liver failure, biliary infection) |
| Key secondary outcomes | improvement of QOL, reduction of liver volume, change of liver function, change of the number of platelet, The rate of a technological success |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | TAE with Embosphere | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) more than 20 years old
2) The patieng who are diacnosed by Computed Tomography, Magnetic resonance imaging or ultra sound and has a symptom such as abdominal distension, abdominal pain,behavioral disorder, respiration disorder, eating disorder,and back pain. 3) Child-Pugh score <6 4) A) Hemoglobin > 8 g/dL B) WBC >3000 /uL and <12000 /uL C) Platelet > 50000 /uL D) normal electocardiogram 5)Performance Status (ECOG)) is 0 to 2. |
|||
| Key exclusion criteria | 1) CRP> 1.0mg/dL
2) Total Bilirubin > 3mg/dL 3) Obstruction of portal vein 4) cancer patient 5) iodine hypersensitivity 6) A patient with a lot of ascites 7) A patient with a lot ofpleural effusion 8) Pregnant women 9) Not eligible for this study based on the decision's of a physician |
|||
| Target sample size | 5 | |||
| Research contact person | |
| Name of lead principal investigator | Saori Nishio |
| Organization | Hokkaido University Hospital |
| Division name | Internal medicine II |
| Address | 15, Nishi 7, Kita-ku, Sapporo, Japan060-8638 |
| TEL | 011-706-5915 |
| saorin@med.hokudai.ac.jp | |
| Public contact | |
| Name of contact person | Takashi Miyakoshi |
| Organization | Hokkaido University Hospotal |
| Division name | Clinical Research and Medical Innovation Center Research and Development Division |
| Address | Kita14 Nishi5, Kita-ku, Sapporo, Hokkaido, 060-8648, Japan |
| TEL | 011-706-7923 |
| Homepage URL | |
| mi_taka_1112@huhp.hokudai.ac.jp | |
| Sponsor | |
| Institute | Hokkaido University Hospotal |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Health, Labour and Welfare |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | JAPAN |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 北海道大学病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000011958 |